For the development of novel synbiotic ingredients with lipid-reducing activity, this study aimed to screen lactic acid bacteria exhibiting lipid-reducing functions, formulate synbiotic compositions through strain combination, and optimize the freeze-drying process. From 80 candidate strains, Lactobacillus pentosus 9–6 and Enterococcus faecalis SMN3–2 were selected based on their high in vitro cholesterol and triglyceride degradation percentage. The results showed that co-culturing these two strains at a 2:1 proportion in combination with lactulose enhanced cholesterol and triglyceride degradation percentage to (70.7 ± 1.0)% and (58.8 ± 0.7)%, respectively. Subsequently, a Box-Behnken response surface design was applied to optimize the cryoprotectant formulation (proportion 1:6) and refine critical processing parameters including static culture for 30 min and pre-freezing at −80 °C for 12 h resulting in a synbiotic lyophilized powder with a viable bacterial count of 4.63 × 10^9 CFU/g, along with cholesterol and triglyceride degradation efficiencies of (62.6 ± 0.6)% and (53.8 ± 0.6)%, respectively. Research findings indicate that the synbiotic system formed by the combination of specific Lactobacillus strains and lactulose functions through a lipid-lowering mechanism, and the lyophilization process effectively preserves its functional efficacy. This synbiotic lyophilized powder can serve as a key functional ingredient in lipid-modulating special dietary foods, health foods, or functional dairy products, offering a potential interventional strategy for regulating lipid metabolism through functional food formulations.
扫码关注我们
求助内容:
应助结果提醒方式:
